Metal organic framework compound as well as preparation method and application thereof
By designing a nano-scale multi-metal organic framework composite, metal ions are combined with iron hydroxyoxide and imidazole frameworks to form a multi-leg morphology and optimize the release of metal ions, the problem of insufficient metal ions in the prior art is solved, and the problem of insufficient metal ions is significantly improved. Improves bactericidal efficiency and reduces cytotoxicity, providing new antibacterial agent design and solutions for the treatment of bacterial infections.
Patent Information
- Application Number
- CN202411326152.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-12-27
AI Technical Summary
Inadequate release of metal ions in the prior art leads to a reduced bactericidal efficiency, and the excessive use and abuse of traditional antibiotics have aggravated the spread of antibiotic resistance, and new antibiotics need to be developed to reduce side effects and promote the development of drug resistance.
Design a nanoscale polymetallic organic framework composite to form a multi-leg morphology by combining metal ions (such as zinc and cobalt) with iron hydroxyl oxide and imidazole frameworks, optimize the release mechanism of metal ions and enhance the mutual interaction with bacteria. Effect and sterilization effect.
It significantly improves the bactericidal effect, reduces cytotoxicity, and especially shows an efficient bactericidal rate under acidic and neutral conditions, and reduces the toxicity to normal cells, providing new antibacterial agent design and solutions for the treatment of bacterial infection.
Smart Images

Figure CN119184112A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of sterilization materials, and specifically to a metal organic framework composite and a preparation method and application thereof; in particular, to a preparation and application method of a metal organic framework composite for killing a variety of pathogenic microorganisms. Background Art
[0002] Bacterial infections affect millions of people every year and are a major challenge to global public health. Typically, these infections are treated with antibiotics. However, the overuse and misuse of traditional antibiotics, as well as imperfect antibiotic stewardship, have exacerbated the spread of antimicrobial resistance. The emergence of multiple pathogenic microorganisms has made the treatment of infections more complicated. In addition to improving antibiotic stewardship, there is an urgent need to develop new antimicrobial agents that should be effective in reducing side effects and not promote the development of heritable resistance. Metal ions can effectively eliminate bacteria through a variety of passive antimicrobial mechanisms and have a low potential to induce resistance. However, when metal ions are used in the form of metal salts or nanoparticles, they are often limited by toxic side effects, especially when the release is not properly controlled. Metal-organic frameworks (MOFs) provide a promising solution as a tunable reservoir of metal ions. MOFs enable controlled and sustained release, thereby minimizing cytotoxicity and enhancing bactericidal effects. The incorporation of bactericidal metal ions (such as silver, cobalt, copper, and zinc ions) into MOFs can significantly reduce toxicity, which is significantly lower than that of free metal ions.
[0003] Although MOFs show obvious advantages in the controlled release of metal ions, existing technologies still have the problem of insufficient local release of bactericidal metal ions. This insufficient local release may lead to a reduction in bactericidal efficiency. Therefore, new strategies need to be developed to enhance the release of local ions, such as by designing stimulus-responsive release mechanisms, or by shortening the release distance to increase local ion concentrations. Existing studies have shown that optimizing the morphology of nanoparticles can improve the interaction between materials and bacteria, which may reduce the diffusion distance of bactericides and enhance the local release effect. In addition, the morphology and surface properties of certain nanoparticles have the potential to mechanically damage bacterial membranes, thereby indirectly improving the bactericidal effect. However, there is still room for further optimization of these technologies to solve the existing problem of insufficient bactericidal efficiency. Summary of the invention
[0004] In view of this, the object of the present invention is to provide a metal organic framework composite and its preparation method and application. The present invention designs a nano-scale multi-metal organic framework composite with a large surface area to enhance the interaction with bacteria and improve the bactericidal effect.
[0005] The objective of the present invention is achieved through the following technical solutions:
[0006] <First aspect>
[0007] 1. A method for preparing a metal organic framework composite, comprising the following steps:
[0008] S1, mixing the surfactant solution with the ferric oxyhydroxide suspension, centrifuging, collecting the precipitate, washing, obtaining surfactant-modified ferric oxyhydroxide, suspending the precipitate in a solvent, and obtaining a surfactant-modified ferric oxyhydroxide suspension;
[0009] S2. Evenly mix a metal salt solution containing at least one metal ion, at least one imidazole ligand solution, and the surfactant-modified ferric oxyhydroxide suspension obtained in step S1, allow to react, centrifuge, collect the precipitate, wash, and dry to constant weight to obtain the metal organic framework composite.
[0010] In step S1, the preparation method of the ferric oxyhydroxide suspension includes the following steps: placing a ferric chloride solution at 60-90°C for reaction for 5-6 hours, and naturally cooling to room temperature; repeatedly washing the reaction product until the washing liquid is neutral; and resuspending the product in water (using deionized water) to obtain a ferric oxyhydroxide suspension.
[0011] In step S1, the concentration of the iron oxyhydroxide suspension is 0.3-0.5 mg / mL.
[0012] In step S1, the surfactant includes one or more of polyvinyl pyrrolidone (PVP), sodium dodecyl sulfate (SDS), and polyethylene glycol (PEG). In the surfactant solution, the mass concentration of the surfactant is 2-5%.
[0013] Preferably, the surfactant is polyvinylpyrrolidone (PVP).
[0014] The mass concentration of the polyvinyl pyrrolidone (PVP) is 2-5%.
[0015] The mass ratio of surfactant to ferric oxyhydroxide is 40-166.7:1.
[0016] In S2, the preparation of the metal salt solution includes dissolving at least one metal salt in a solvent, wherein the metal salt includes one or more of zinc salt and cobalt salt, preferably a combination of zinc salt and cobalt salt, and the solvent includes methanol and / or ethanol.
[0017] The preparation method of the metal salt solution in S2 comprises the following steps:
[0018] The zinc salt and the cobalt salt are dissolved in a solvent to obtain a metal salt solution; in the metal salt solution, the concentrations of the zinc ions and the cobalt ions are both 0.001-0.002 mol / L.
[0019] The zinc salt is preferably zinc nitrate or a hydrate thereof; the cobalt salt is preferably cobalt nitrate or a hydrate thereof.
[0020] As an implementation method of the present invention, the preparation method of the metal salt solution in S2 comprises the following steps:
[0021] Zinc nitrate hexahydrate and cobalt nitrate hexahydrate are dissolved in a solvent (methanol and / or ethanol) to obtain a metal salt solution. In the metal salt solution, the concentrations of zinc ions and cobalt ions are both 0.001-0.002 mol / L.
[0022] In the metal salt solution, the theoretical molar ratio of zinc ions to cobalt ions is 1:1-2:1.
[0023] In S2, the imidazole ligand solution includes one or more of imidazole, 2-methylimidazole, benzimidazole, and 4,5-dicyanoimidazole; and the concentration of the imidazole ligand solution is 2-5 g / L.
[0024] Preferably, the imidazole ligand solution is a 2-methylimidazole solution with a concentration of 2-5 g / L.
[0025] In S2, the concentration of the surfactant-modified iron oxyhydroxide suspension is 0.3-0.6 mg / mL.
[0026] In S2, the volume ratio of metal salt solution: imidazole ligand solution: surfactant-modified iron oxyhydroxide suspension is (5-9):(5-9):(3-7).
[0027] In S2, the static reaction conditions are: static reaction in a 40-50°C water bath for 20-30 hours.
[0028] <Second Aspect>
[0029] The present invention also provides a metal organic framework composite prepared by the preparation method as described above.
[0030] <Third Aspect>
[0031] The use of the metal organic framework composite in killing various pathogenic microorganisms also falls within the protection scope of the present invention.
[0032] The multiple pathogenic microorganisms include one or more of Escherichia coli, extended-spectrum β-lactamase-producing Escherichia coli, Pseudomonas aeruginosa, carbapenemase-producing Pseudomonas aeruginosa, Klebsiella pneumoniae, carbapenemase-producing Klebsiella pneumoniae, Alcaligenes faecalis, Staphylococcus aureus, Burkholderia cepacia, and Pseudomonas putida.
[0033] The ratio of the metal organic framework complex to the bacteria is 100 μg: (10 5 ~10 7) CFU. After 2 hours at room temperature, the sterilization rate reached more than 90%.
[0034] The invention uses ferric chloride solution to synthesize oxyhydroxide nanorods, and uses polyvinyl pyrrolidone to modify the surface of the oxyhydroxide nanorods; the oxyhydroxide nanorods present a uniform spindle-shaped morphology, an average length of 450±40nm, and an angular width of a sharp corner of 10±2nm.
[0035] The diameter of the metal organic framework complex prepared by the invention is 50±2nm.
[0036] The composite can effectively control the release of metal ions, enhance the bactericidal effect and reduce cytotoxicity through the combination of Zn / Co bimetallic zeolite imidazole framework and iron oxyhydroxide.
[0037] The preferred application conditions are that the complex exhibits good bactericidal effects under both acidic and neutral conditions, especially under pH conditions of 5-7, the bactericidal rate of the complex can reach the highest, and the cytotoxicity is relatively low.
[0038] Compared with the prior art, the present invention has the following beneficial effects:
[0039] 1. In terms of material structure and function, the present invention uses ferric hydroxide as a rigid carrier and a Zn / Co bimetallic zeolite imidazole framework as the main source of bactericidal metal ions. The metal-organic framework complex formed by the combination of the two has a multi-foot morphology. Compared with the single ferric hydroxide or Zn / Co bimetallic zeolite imidazole framework, this multi-foot morphology enables the complex to have a stronger bacterial binding ability. The addition of ferric hydroxide stabilizes the Zn / Co bimetallic zeolite imidazole framework, prevents its aggregation, and promotes the stable and uniform release of bactericidal metal ions. The sharp corners of ferric hydroxide can enhance adhesion and penetration with bacterial cells, causing mechanical interference to the bacterial membrane.
[0040] 2. In terms of bactericidal and cytotoxicity, the complex of the present invention can effectively control the release of metal ions, significantly enhance the local release of bactericidal metal ions, and thus enhance the bactericidal effect. The complex has a good bactericidal effect under both acidic and neutral conditions, with the highest bactericidal rate at pH 5-7, and also shows significant efficacy against highly resistant multidrug-resistant bacteria.
[0041] 3. This innovative approach provides a new perspective for the design of antimicrobial agents and offers an effective solution for the treatment of bacterial infections and the application of MOF (metal-organic framework)-based materials in biomedicine.
[0042] 4. The composite of the present invention significantly enhances the local release of bactericidal metal ions and reduces toxicity to normal cells by optimizing the structural design of the metal organic framework and iron oxyhydroxide, thereby enhancing the bactericidal effect while reducing cytotoxicity, and has high practicality and operability. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Other features, objects and advantages of the present invention will become more apparent from the detailed description of non-limiting embodiments made with reference to the following drawings:
[0044] Figure 1 Characterization diagram of the metal organic framework composite of Example 1; A) scanning electron microscope image, B, C) transmission electron microscope images, D) scanning transmission electron microscope image and corresponding element distribution diagram; wherein the scale of Co, Zn, and O is the same as that of Fe;
[0045] Figure 2 is a transmission electron microscopy image of Comparative Example 2;
[0046] Figure 3 The figure is a schematic diagram of the synthesis process of the metal organic framework composite of the present invention, and a schematic diagram of the sterilization mechanism;
[0047] Figure 4 This is a scanning electron microscope image of iron oxyhydroxide in Example 1. DETAILED DESCRIPTION
[0048] The present invention is described in detail below in conjunction with embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but are not intended to limit the present invention in any form. It should be noted that, for those of ordinary skill in the art, some adjustments and improvements can also be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.
[0049] In the following examples and comparative examples:
[0050] Polyvinylpyrrolidone (PVP, average molecular weight about 40,000).
[0051] Figure 3 It is a schematic diagram of the synthesis process of the metal organic framework composite of the present invention, and a schematic diagram of the bactericidal mechanism (mainly including membrane destruction and inducing the production of reactive oxygen species (ROS) in bacteria).
[0052] Example 1 Metal-organic framework composite and preparation method thereof
[0053] 1. Preparation of iron oxyhydroxide suspension
[0054] Accurately weigh an appropriate amount of ferric chloride to prepare a 0.2 mol / L ferric chloride solution; place the ferric chloride solution at 70°C for 5 hours and cool it naturally to room temperature; separate the product by centrifugation, and repeatedly wash the reaction product with deionized water until the washing solution is neutral. Subsequently, the product is resuspended in deionized water and adjusted to a final concentration of 0.4 mg / mL to obtain a hydroxyl iron suspension (see the scanning electron microscope image of hydroxyl iron). Figure 4 , iron oxyhydroxide presents a uniform spindle-shaped morphology with an average length of 450±40nm and an angular width of 10±2nm at the sharp corners).
[0055] 2. Surface modification of iron oxyhydroxide
[0056] Mix 400 mL of 2.5% (mass concentration) polyvinyl pyrrolidone (PVP) solution with 400 mL of the oxyhydroxide iron suspension obtained in step 1, and stir at room temperature for 24 hours to allow PVP to adsorb on the surface of the oxyhydroxide iron; after the stirring, collect the precipitate by centrifugation to separate the product, and wash it several times with methanol to remove the unadsorbed PVP; redisperse the product (polyvinyl pyrrolidone-modified oxyhydroxide iron) in methanol and adjust the final concentration to 0.4 mg / mL to obtain a polyvinyl pyrrolidone-modified oxyhydroxide iron suspension.
[0057] 3. Preparation of Metal-Organic Framework Composites
[0058] 3.1. Prepare a metal salt solution: Weigh 0.1071 g of zinc nitrate hexahydrate and 0.1047 g of cobalt nitrate hexahydrate respectively, and dissolve them in 200 mL of methanol to obtain a metal salt solution.
[0059] 3.2. Prepare 2-methylimidazole solution: weigh 0.4712 g of 2-methylimidazole and dissolve it in 200 mL of methanol to obtain a ligand solution.
[0060] 3.3. Mixing reaction: 7 mL of metal salt solution and 7 mL of 2-methylimidazole solution were measured and mixed evenly. Then, 5 mL of the PVP-modified iron oxyhydroxide suspension obtained in step 2 was added and stirred to mix the components evenly.
[0061] 3.4. Stand-still reaction: The mixture was placed in a 40°C water bath and allowed to stand for 24 hours. After the reaction was completed, the product was separated by centrifugation and repeatedly washed with methanol to remove unreacted raw materials and impurities. The product was placed in a vacuum drying oven and dried at 40°C for 30 minutes. From the transmission electron microscopy image ( Figure 1 C) Statistics show that the Zn / Co bimetallic zeolite imidazole framework with a diameter of about 50±2 nm is uniformly attached to the surface of the oxyhydroxide iron (the arrow points to the Zn / Co bimetallic zeolite imidazole framework) to form a metal organic framework complex. The synthesis flow chart of the metal organic framework complex is shown in FIG. Figure 3 The characterization results are shown in Figure 1 As shown, A) scanning electron microscope image, B, C) transmission electron microscope images, D) scanning transmission electron microscope image and corresponding element distribution map, the scale of Co, Zn, and O in D) is the same as that of Fe.
[0062] Example 2 Metal-organic framework composite and preparation method thereof
[0063] 1. Preparation of ferric oxyhydroxide suspension Accurately weigh an appropriate amount of ferric chloride to prepare a 0.3 mol / L ferric chloride solution; place the ferric chloride solution at 80°C for 4 hours and cool it naturally to room temperature; repeatedly wash the reaction product with deionized water until the washing solution is neutral. Subsequently, resuspend the product in deionized water and adjust the final concentration to 0.5 mg / mL to obtain a ferric oxyhydroxide suspension.
[0064] 2. Surface modification of iron oxyhydroxide
[0065] 500 mL of 3% polyvinyl pyrrolidone (PVP) solution was mixed with the oxyhydroxide iron suspension obtained in step 1, and stirred at room temperature for 18 hours to allow PVP to adsorb on the surface of the oxyhydroxide iron; after the stirring was completed, the precipitate was collected by centrifugation to separate the product, and washed several times with methanol to remove the unadsorbed PVP; the product (polyvinyl pyrrolidone-modified oxyhydroxide iron) was redispersed in methanol and adjusted to a final concentration of 0.5 mg / mL to obtain a polyvinyl pyrrolidone-modified oxyhydroxide iron suspension.
[0066] 3. Preparation of Metal-Organic Framework Composites
[0067] 3.1. Prepare metal salt solution: Weigh 0.1285 g zinc nitrate hexahydrate and 0.1256 g cobalt nitrate hexahydrate respectively, dissolve in 250 mL methanol to obtain metal salt solution.
[0068] 3.2. Prepare 2-methylimidazole solution: weigh 0.5654 g of 2-methylimidazole and dissolve it in 250 mL of methanol to obtain a ligand solution.
[0069] 3.3. Mixing reaction: 8 mL of metal salt solution and 8 mL of 2-methylimidazole solution were measured and mixed evenly. Then, 6 mL of the PVP-modified iron oxyhydroxide suspension obtained in step 2 was added and stirred to mix the components evenly.
[0070] 3.4. Standing reaction: The mixed solution was placed in a 45°C water bath for standing reaction for 20 hours. After the reaction was completed, the product was separated by centrifugation and repeatedly washed to remove unreacted raw materials and impurities. The product was placed in a vacuum drying oven and dried at 45°C for 25 minutes to obtain a Zn / Co bimetallic zeolite imidazole framework with a diameter of 60±3nm uniformly attached to the surface of the oxyhydroxide iron to form a metal organic framework complex.
[0071] Comparative Example 1 Preparation of Iron Oxyhydroxide
[0072] Accurately weigh an appropriate amount of ferric chloride to prepare a 0.2 mol / L ferric chloride solution; place the ferric chloride solution at 70°C for reaction for 5 hours and naturally cool to room temperature; separate the product by centrifugation, repeatedly wash the reaction product with deionized water until the washing liquid is neutral, and dry it in an oven at 60°C overnight to obtain iron oxyhydroxide nanorods.
[0073] Comparative Example 2 Preparation of a Zn / Co bimetallic zeolite imidazole framework
[0074] 1. Prepare metal salt solution: Weigh 0.1071 g zinc nitrate hexahydrate and 0.1047 g cobalt nitrate hexahydrate respectively, dissolve in 200 mL methanol to obtain metal salt solution.
[0075] 2. Prepare 2-methylimidazole solution: weigh 0.4712 g of 2-methylimidazole and dissolve it in 200 mL of methanol to obtain a ligand solution.
[0076] 3. Mixing reaction: Measure 7 mL of metal salt solution and 7 mL of 2-methylimidazole solution and mix them evenly.
[0077] 4. Stand and react: Place the mixture in a 40°C water bath and stand and react for 24 hours. After the reaction is completed, separate the product by centrifugation and wash repeatedly to remove unreacted raw materials and impurities. Place the product in a vacuum drying oven and dry it at 40°C for 30 minutes to obtain a Zn / Co bimetallic zeolite imidazole framework. See the characterization diagram Figure 2 .
[0078] Comparative Example 3: Iron oxyhydroxide without surface modification
[0079] 1. Preparation of iron oxyhydroxide suspension
[0080] Accurately weigh an appropriate amount of ferric chloride to prepare a 0.2 mol / L ferric chloride solution; place the ferric chloride solution at 70°C for 5 hours and naturally cool to room temperature; separate the product by centrifugation, and repeatedly wash the reaction product with deionized water until the washing solution is neutral. Subsequently, resuspend the product in deionized water and adjust the final concentration to 0.4 mg / mL to obtain a ferric oxyhydroxide suspension.
[0081] 2. Preparation of Metal-Organic Framework Composites
[0082] 2.1. Prepare a metal salt solution: Weigh 0.1071 g of zinc nitrate hexahydrate and 0.1047 g of cobalt nitrate hexahydrate respectively, and dissolve them in 200 mL of methanol to obtain a metal salt solution.
[0083] 2.2. Prepare 2-methylimidazole solution: weigh 0.4712 g of 2-methylimidazole and dissolve it in 200 mL of methanol to obtain a ligand solution.
[0084] 3.3. Mixing reaction: 7 mL of metal salt solution and 7 mL of 2-methylimidazole solution were measured and mixed evenly. Then, 5 mL of the iron oxyhydroxide suspension obtained in step 1 was added and stirred to mix the components evenly.
[0085] Comparative Example 4: Changing the metal salt ratio
[0086] The difference between this comparative example and Example 1 is that in step 3.1, the ratio of zinc nitrate hexahydrate to cobalt nitrate hexahydrate is different from that in Example 1.
[0087] Step 3.1 is specifically as follows: 0.05355 g of zinc nitrate hexahydrate and 0.15605 g of cobalt nitrate hexahydrate are weighed respectively, and dissolved in 200 mL of methanol to obtain a metal salt solution.
[0088] The remaining steps are the same as in Example 1
[0089] Comparative Example 5
[0090] The difference between this comparative example and Example 1 is that in step 3.1, cobalt nitrate hexahydrate is replaced by nickel nitrate hexahydrate.
[0091] Performance test case
[0092] 1. Preparation of bacterial samples.
[0093] Use an inoculation loop to take a small amount of frozen bacterial liquid and streak it in four zones on TSA solid medium. Incubate it in a 37°C or 30°C incubator for 18 hours to obtain a single colony. Pick a single colony from the solid medium and inoculate it in 25 ml of TSB liquid medium. Place it on a constant temperature shaker at 37°C or 30°C, shake at 175 rpm, and incubate it for 16 hours. Take 1 ml of bacterial suspension and centrifuge to obtain a bacterial cell pellet. Wash the bacteria twice with PBS to remove the culture medium, resuspend the bacterial pellet in PBS, and dilute the bacterial suspension to a concentration of 10 6 CFU / mL, for future use.
[0094] Among them, the culture temperature of Escherichia coli (ATCC 25922) and Staphylococcus aureus (CICC 24064) is 37°C. The culture temperature of Pseudomonas aeruginosa (CICC 21643), Klebsiella pneumoniae (CICC 20093), Alcaligenes faecalis (ATCC 35655), Burkholderia cepacia (CICC 10828) and Pseudomonas putida (ATCC 12633) is 30°C.
[0095] 2. Sterilization
[0096] The materials prepared in Examples 1, 2 and Comparative Examples 1-5 were added to 10 6 CFU / mL of Escherichia coli suspension was shaken at room temperature for 2 hours, then 100 μL of the bacterial solution was diluted and spread on TSA solid culture medium (Qingdao Haibo Biotechnology Co., Ltd., product number HB0177-1), and the colonies were counted after 24 hours of incubation to calculate the bactericidal rate.
[0097] Sterilization rate = (number of colonies in the control group - number of colonies in the experimental group) / number of colonies in the control group × 100%
[0098] The calculated sterilization rate results are shown in Table 1:
[0099] Table 1
[0100]
[0101] The results showed that the composite material had a significant bactericidal effect on bacteria such as Escherichia coli and Pseudomonas aeruginosa. See Table 1.
[0102] The above describes the specific embodiments of the present invention. It should be understood that the present invention is not limited to the above specific embodiments, and those skilled in the art may make various modifications or variations within the scope of the claims, which do not affect the essence of the present invention.
Claims
1. A method for preparing a metal organic framework composite, characterized in that: The steps include: S1, mixing the surfactant solution with the ferric oxyhydroxide suspension, centrifuging, collecting the precipitate, washing, obtaining surfactant-modified ferric oxyhydroxide, suspending the precipitate in a solvent, and obtaining a surfactant-modified ferric oxyhydroxide suspension; S2. Evenly mix a metal salt solution containing at least one metal ion, at least one imidazole ligand solution, and the surfactant-modified ferric oxyhydroxide suspension obtained in step S1, allow to react, centrifuge, collect the precipitate, wash, and dry to constant weight to obtain the metal organic framework composite.
2. The preparation method according to claim 1, characterized in that: In step S1, the preparation method of the ferric oxyhydroxide suspension includes the following steps: placing a ferric chloride solution at 60-90° C. for hydrolysis reaction for 5-6 hours, and naturally cooling to room temperature; repeatedly washing the reaction product until the washing solution is neutral; and resuspending the product in water to obtain a ferric oxyhydroxide suspension.
3. The preparation method according to claim 1, characterized in that: In step S1, the concentration of the iron oxyhydroxide suspension is 0.3-0.5 mg / mL; And / or, in step S1, the surfactant includes one or more of polyvinyl pyrrolidone, sodium lauryl sulfate, and polyethylene glycol; And / or, in the surfactant solution, the mass concentration of the surfactant is 2-5%.
4. The preparation method according to claim 1, characterized in that: In S2, the preparation of the metal salt solution includes dissolving at least one metal salt in a solvent, wherein the metal salt includes one or more of zinc salt and cobalt salt.
5. The preparation method according to claim 1, characterized in that: The preparation method of the metal salt solution in S2 comprises the following steps: The zinc salt and the cobalt salt are dissolved in a solvent to obtain a metal salt solution; in the metal salt solution, the concentrations of the zinc ions and the cobalt ions are both 0.001-0.002 mol / L.
6. The preparation method according to claim 1, characterized in that: In S2, the imidazole ligand solution includes one or more of imidazole, 2-methylimidazole, benzimidazole, and 4,5-dicyanoimidazole.
7. The preparation method according to claim 1, characterized in that: In S2, the volume ratio of metal salt solution: imidazole ligand solution: surfactant-modified iron oxyhydroxide suspension is (5-9):(5-9):(3-7).
8. The preparation method according to claim 1, characterized in that: In S2, the static reaction conditions are: static reaction in a 40-50°C water bath for 20-30 hours.
9. A metal organic framework composite prepared by the preparation method according to any one of claims 1 to 8.
10. A use of the metal organic framework composite as claimed in claim 9, characterized in that: The application is for killing a variety of pathogenic microorganisms; the multiple pathogenic microorganisms include one or more of Escherichia coli, extended-spectrum β-lactamase-producing Escherichia coli, Pseudomonas aeruginosa, carbapenemase-producing Pseudomonas aeruginosa, Klebsiella pneumoniae, carbapenemase-producing Klebsiella pneumoniae, Alcaligenes faecalis, Staphylococcus aureus, Burkholderia cepacia, and Pseudomonas putida.
Citation Information
Cited By
Preparation method of water purification filler with adsorption and photo-Fenton properties
CN119869619A
